Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (261-270 of 374) with videos related to

Pageof 38
Sort By:
Haematologica|February 11, 2014
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumBirgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Blood|August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHLGerman Ott, Marita Ziepert, Wolfram Klapper, et al.
British Journal of Haematology|February 6, 2007
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanismsAndrew J Davies, Andreas Rosenwald, George Wright, et al.
Leukemia|March 11, 2025
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesSelina Glaser, Anja Fischer, Juan Emilio Martínez-Manjón, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Blood|May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsEllen Leich, Itziar Salaverria, Silvia Bea, et al.
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
Pageof 38

Showing results (261-270 of 374) with videos related to

Sort By:
Pageof 38
Haematologica|February 11, 2014
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker ConsortiumBirgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Blood|August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHLGerman Ott, Marita Ziepert, Wolfram Klapper, et al.
British Journal of Haematology|February 6, 2007
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanismsAndrew J Davies, Andreas Rosenwald, George Wright, et al.
Leukemia|March 11, 2025
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesSelina Glaser, Anja Fischer, Juan Emilio Martínez-Manjón, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Blood|May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsEllen Leich, Itziar Salaverria, Silvia Bea, et al.
Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
Pageof 38